Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Publish Press Release  |  Top Stories  |  Publishers  |  Tool & Tips  |  Today's News  |  Weekly News  |  Monthly News  |  News By Date  |  News by Region  |  News by Category
All Press Releases for Sep 5th, 2012 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    



Us Capital Partners Secures 2 Million In Financing Through Asset Sale For Mesa Pharmacy Inc

Private investment bank secures strategic financing for California-based pharmaceutical compound manufacturer. Sep 5th, 2012. 

India (FreePressBox.com) Sep 5th, 2012 -- 

San Francisco, CA, September 05, 2012 -- US Capital Partners, LLC has secured 2 million in financing through a successful sale of accounts receivable for Mesa Pharmacy, Inc. (Mesa Pharmacy), based in Irvine, CA. US Capital Partners is a private investment bank, direct lender, and lead debt and equity financial participant and arranger that specializes in structuring and providing the best available financing for small to lower middle market companies.

Mesa Pharmacy needed to retire existing senior debt and locate additional working capital for expansion and market entry, said Ed Kurtz, Chief Operating Officer at Mesa Pharmacy. US Capital Partners assisted us in achieving these objectives by successfully securing 2 million in financing for the company through an asset sale.

We are delighted to have assisted this growing California pharmacy business, said Jeffrey Sweeney, CEO and Managing Director at US Capital Partners. Mesa Pharmacy was locked in an inappropriate financing structure, which was hindering its growth. US Capital Partners successfully arranged 2 million for the company through a sale of its medical receivables within the California workers compensation industry. Our innovative and pragmatic underwriting solutions and our in-depth understanding of medical receivables was critical to closing.

About Mesa Pharmacy, Inc.
Headquartered in Irvine, CA, Mesa Pharmacy provides customized compounds for pain management, bio-identical hormone replacement therapy, and a variety of other applications. Mesa Pharmacy is a wholly owned operating subsidiary of Pharmacy Development Corp., established in 2007 to develop an alternative to typical oral medication for pain management. Working with California-based physicians for industrial pain management, Mesa Pharmacy has successfully formulated prescription-strength topical medication as an alternative to commonly used oral medications.

About US Capital Partners, LLC
Since 1998, US Capital Partners (www.uscapitalpartners.net) has been providing prompt, innovative, and reliable financing solutions including lending, corporate financing, and debt re-structuring to businesses across the United States and abroad. US Capital Partners is a private investment bank that specializes in asset-based debt and equity financing for small to middle market private and public companies. The companys innovative approach allows it to provide the best financing available, not only for companies in excellent financial condition, but also for companies that may have been refused credit by traditional lenders.

If you would like to know more about how your business can secure the funding it needs, email Jeffrey Sweeney, CEO and Managing Director, at jsweeney@uscapitalpartners.net or call (415) 889-1010.

Contact Information:
Name: 0
About the author
...

Company: 0
Telphone: 0
E-Mail: ***


Does this story fit one of these flags? If so, click it! share to your friends and followers!
 
 
 
 
 
 
 
Rate this news:
  • Currently 0/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
0 / 5 stars - 0 vote(s)

Free Press Release Service & Press Release Distribution News Supplied By FreePressBox.com

Add New Comments


Your Name *
Your Email: *
Your Comments: *
Enter Validation Code: * Captcha  
 


MGuru
452 news online
Follow us on Facebook
Follow us on Twitter
Disclaimer:

FreePressBox disclaims any content contained in this press release. We are unable to assist you with any information regarding this release. If you have any questions regarding information or any copyright issue in this press release, please contact us. Please see our complete Terms of Service disclaimer for more information.